Wen-Cheng Wu
Overview
Explore the profile of Wen-Cheng Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ji X, Guo Y, Wang L, Wu W, Wang J, He J, et al.
J Neuroinflammation
. 2024 Jan;
21(1):29.
PMID: 38246987
Demyelination and failure of remyelination in the central nervous system (CNS) characterize a number of neurological disorders. Spontaneous remyelination in demyelinating diseases is limited, as oligodendrocyte precursor cells (OPCs), which...
2.
Wang M, Cai W, Yang A, Wang C, Zhang C, Liu W, et al.
Cancer Lett
. 2022 Jul;
545:215827.
PMID: 35842018
The endothelium is the critical barrier that controls transendothelial communications. Blood vessels in cancer tissue are poorly developed and highly permeable. However, it is poorly understood how circulating cancer cells...
3.
Wu W, Tian J, Xiao D, Guo Y, Xiao Y, Wu X, et al.
Nanoscale
. 2022 Jan;
14(6):2393-2410.
PMID: 35088795
Targeted and effective drug delivery to central nervous system (CNS) lesions is a major challenge in the treatment of multiple sclerosis (MS). Extracellular vesicles (EVs) have great promise as a...
4.
Wu X, Liao B, Xiao D, Wu W, Xiao Y, Alexander T, et al.
Biomater Sci
. 2021 Dec;
10(3):714-727.
PMID: 34928285
Demyelination is a critical neurological disease, and there is still a lack of effective treatment methods. In the past two decades, stem cells have emerged as a novel therapeutic effector...
5.
Xiao Y, Tian J, Wu W, Gao Y, Guo Y, Song S, et al.
Bioact Mater
. 2021 Nov;
9:373-384.
PMID: 34820577
The lack of targeted and high-efficiency drug delivery to the central nervous system (CNS) nidus is the main problem in the treatment of demyelinating disease. Extracellular vesicles (EVs) possess great...
6.
Guo Y, Wang N, Wu W, Li C, Chen R, Zhang Y, et al.
J Oncol
. 2021 Nov;
2021:6473038.
PMID: 34777498
Short-stranded miRNAs are single-stranded RNA molecules involved in the regulation of gene expression. miRNAs are involved in a variety of cellular physiological processes, including cell proliferation, differentiation, and apoptosis. miR-23b...
7.
Han B, Zhang Y, Ye Z, Xiao Y, Rasouli J, Wu W, et al.
Immunology
. 2021 Jan;
163(2):185-200.
PMID: 33480040
Montelukast is a leukotriene receptor antagonist that is known to prevent allergic rhinitis and asthma. Blocking the Cysteinyl leukotriene receptor (CysLTR1), one of the primary receptors of leukotrienes, has been...
8.
Wu W, Song S, Zhang Y, Li X
Front Immunol
. 2020 Oct;
11:579043.
PMID: 33072123
Autoimmune diseases are conditions that emerge from abnormal immune responses to natural parts of the body. Extracellular vesicles (EVs) are membranous structures found in almost all types of cells. Because...
9.
Duan S, Liu H, Wu W, Yang K, Zhang Z, Liu S
Orthop Surg
. 2019 Mar;
11(1):34-41.
PMID: 30834705
Objective: To assess the clinical efficacy of TiRobot-assisted percutaneous cannulated screw fixation in the treatment of femoral neck fractures. Methods: From September 2015 to July 2017, 26 patients with unilateral...
10.
Chung K, Chen P, Kuo C, Tsai S, Huang S, Wu W
Psychiatry Res
. 2018 Jun;
267:7-11.
PMID: 29879603
Patients with schizophrenia have higher mortality and shortened life expectancy than the general population, and cardiovascular disease (CVD) accounts for up to 50% cases of early mortality in schizophrenia. We...